Philip Morris International presents the integrated ratio 2024 and progress on the journey to a smoke -free future
Philip Morris International has published the sixth annually integrated report and thus marked 10 years of business transformation and communication in the field of sustainability.
The document emphasizes the continuous progress made by the company to advance in achieving the proposed objectives to replace cigarettes with smoke -free alternative products as soon as possible and to provide long -term value for shareholders and other interested factors.
The integrated ratio 2024 highlights the continuous expansion of the smoke-free alternatives produced by PMIs in markets around the world, including Romania, as well as the social and environmental programs implemented with these products and in parallel-including the implementation of marketing and sales practices and the efforts to reduce post-consumption. In addition, the PMI reports progress on several levels as follows: promoting an inclusive and collaborative working environment, improving the quality of life of people in the supply chain, decarbonizing operations and value chain, as well as conservation of nature and biodiversity.
“The integrated report 2024 celebrates a reference year that has marked the tenth anniversary of the marketing of our IQOS and Zyn smoke -free products and our journey towards making one of the most ambitious transformations of a business in modern history.” said Jacek Olczak, Chief Executive Officer, Philip Morris International. “I am very optimistic about the progress of our business. Through the dedicated efforts of our employees, not only did I maintain the rhythm, but accelerated it and thus achieved goals that, just a few years ago, seemed too ambitious to be achieved.”
In Romania, the company reaffirms its commitment to sustainability through innovative and sustainable practices and implements numerous social and environmental initiatives for a more tangible impact in the community in which it operates.
“In Romania, the investments made by the PMI have given us an extraordinary opportunity for innovation and development. We act responsibly and sustainably to build a smoke-free future. Romania represents a central pillar in the PMI strategy to build this future without smoke, and the factory in Otopeni is a clear example of our firm commitment to innovation as a result of investments of over 730 million.” said Mircea Scaunașu, Managing Director, Philip Morris Romania.
“We understand the importance of setting ambitious but realistic goals that lead to the success of our business. Our sustainability index has played an important role in ensuring that we have balanced ambitions, objective measuring methods, while the improved governance of non -financial data helps us to report precisely and consistently.” said Jennifer Motles, Chief Sustainability Officer, Philip Morris International.
Go to PMI.com/Sustainebility to read the integrated report 2024, a series of case studies and local sustainability stories, as well as the KPI protocol for sustainability.
Philip Morris International: For a smoke -free future
Philip Morris International (PMI) is an international top-in tobacco industry that aims to build a smoke-free future and expand, in the long term, the portfolio of products outside the product sector containing tobacco or nicotine. The current product portfolio of the company consists mainly in cigarettes and smoke -free products. Since 2008, the PMI has invested over $ 14 billion to develop, scientifically substantiate and market innovative smoke -free products for adults who would continue to smoke, in order to completely stop the sale of cigarettes. For this, world scientific evaluation capacities have been built, especially in preclinical fields, such as systems toxicology, in clinical and behavioral research, as well as in market introduction. In 2022, the PMI purchased Swedish Match – leader in the manufacture and marketing of nicotine products for oral use – and is thus at the forefront of companies that promote a smoke -free future through its brands. Iqos and
Zyn. Following a solid analysis based on scientific evidence, the US Food and Drug Administration (FDA) authorized the marketing of the SNUS General product and Nicotine Zyn envelopes at Swedish Match and some versions of the device. Iqos Developed by the PMI, as well as the related supplies – the first such authorizations in the respective categories. Versions of the device Iqos And of the related consumables, as well as of the SNUS General product, for the first time they obtained the authorization as a modified risk tobacco products. On December 31, 2024, smoke -free products developed by the PMI were available for sale in 95 markets, and PMI estimates that about 38.6 million adults from all over the world, which would otherwise continue to smoke, use the smoke -free products of the PMI. Smoke -free products represented about 39% of the total net income of the PMI in 2024. With a solid base and significant expertise in life sciences, the PMI has the ambition to expand in wellness and health care and aims to improve the quality of life by providing integrated health experiences.
For more information you can visit www.pmi.com and www.pmiscience.com
Predictive/prospective statements and warnings
This press release contains projections on the evolution of results and objectives, including statements concerning the expected financial or operational performance, business plans and strategies.
The realization of future results is subject to inaccurate risks, uncertainties and assumptions. If the risks or uncertainties are materialized or the basic assumptions prove inaccurate, the real results could vary significantly from those contained in such prospective statements. In accordance with the secure port type provisions of the dispute reform act on the 1995 private securities, the PMI identifies important factors that, individually or as a whole, could make the expected results and the real ones to differ from those found in any predictive statements made by the PMI.
The business risks of the PMI include: increased excise duties and discriminatory tax structures; increasing marketing and regulatory restrictions that could reduce our competitiveness, eliminate the ability to communicate with adult consumers or prohibit certain products on certain markets or countries; concerns about the use of tobacco and other products containing nicotine and exposure to environmental smoke; disputes related to tobacco consumption and intellectual property; competition/competition; the effects of economic, regulatory and political evolution at global level, but also of the country, natural disasters and conflicts; the impact and consequences of Russia's invasion in Ukraine; changes in the behavior of the adult smoker; Covid-19 impact on PMI; income lost as a result of counterfeiting goods, smuggling and cross -border purchases; government investigations; unfavorable currency exchange rates and foreign currency devaluation and limitations of the capacity to repatriate the funds; unfavorable changes in the law on profit tax; unfavorable changes in cost, availability and quality of tobacco and other agricultural products and raw materials, as well as components and materials for electronic devices; and the integrity of its information systems and the effectiveness of its data privacy policies. The PMI profitability can also be negatively affected if its attempts to produce and market low -risk products fail or if regulation or taxation do not distinguish between such alternatives and conventional cigarettes; if it fails to successfully introduce new products, if they cannot expand their portfolio of products internally or through purchases and the development of strategic business relationships; if it is not able to attract and retain the best global talents, including women or new various talents; or if he cannot integrate successfully and make the expected benefits from recent transactions and purchases. Future results are also subject to a lower predictability of the performance of our category of low -risk products.
The PMI is subject to other detailed risks from time to time in its public documents, including the annual report of the PMI and the 10-K form for the fourth quarter and the entire year concluded on December 31, 2024. The PMI warns that the above list of important factors does not constitute a complete discussion of all risks and possible uncertainties. The PMI does not commit to update any prospective statement, which takes place at different times, unless this is necessary in the normal course of its obligations regarding public communication.
